Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LLY

Lilly(Eli) & Co

Sep 12 • 04:00PM ET

755.39

-0.89 -0.12 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN AMGN PFE SNY BMY GSK

| Held by: VTI VOO SPY IVV VUG XLV VIG IWF QUAL VHT

Scroll to Statements

Index	S&P 500	P/E	50.09	EPS (ttm)	15.08	Insider Own	10.34%	Shs Outstand	946.83M	Perf Week	3.88%
Market Cap	714.94B	Forward P/E	25.03	EPS next Y	30.18	Insider Trans	-0.28%	Shs Float	848.58M	Perf Month	14.37%
Enterprise Value	751.38B	PEG	1.21	EPS next Q	6.36	Inst Own	73.68%	Short Float	0.95%	Perf Quarter	-6.98%
Income	13.80B	P/S	13.42	EPS this Y	75.82%	Inst Trans	-0.29%	Short Ratio	1.84	Perf Half Y	-5.77%
Sales	53.26B	P/B	39.14	EPS next Y	32.15%	ROA	15.97%	Short Interest	8.04M	Perf YTD	-2.15%
Book/sh	19.30	P/C	201.62	EPS next 5Y	41.46%	ROE	86.70%	52W High	942.35 -19.84%	Perf Year	-16.18%
Cash/sh	3.75	P/FCF	146.36	EPS past 3/5Y	24.14% 18.77%	ROIC	26.31%	52W Low	623.78 21.10%	Perf 3Y	142.42%
Dividend Est.	5.87 (0.78%)	EV/EBITDA	30.88	Sales past 3/5Y	16.73% 15.08%	Gross Margin	82.64%	Volatility	2.18% 2.28%	Perf 5Y	400.56%
Dividend TTM	5.80 (0.77%)	EV/Sales	14.11	EPS Y/Y TTM	88.21%	Oper. Margin	42.13%	ATR (14)	18.59	Perf 10Y	825.72%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	1.00	Sales Y/Y TTM	36.83%	Profit Margin	25.91%	RSI (14)	58.60	Recom	1.48
Dividend Gr. 3/5Y	15.21% 15.05%	Current Ratio	1.28	EPS Q/Q	91.71%	SMA20	3.78%	Beta	0.46	Target Price	913.17
Payout	44.39%	Debt/Eq	2.18	Sales Q/Q	37.64%	SMA50	1.78%	Rel Volume	0.50	Prev Close	756.28
Employees	47000	LT Debt/Eq	1.87	Earnings	Aug 07 BMO	SMA200	-3.94%	Avg Volume	4.38M	Price	755.39
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.70% 5.80%	Trades		Volume	2,195,366	Change	-0.12%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498

Show Previous Ratings

Today 07:45AM	2 Beaten-Down Stocks to Buy and Hold Forever (Motley Fool)
06:42AM	3 No-Brainer Dividend Stocks to Buy in September (Motley Fool)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
12:56PM	GLP-1 obesity pills face off in head-to-head trial (CNBC TV)
09:21AM	AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock (Zacks)
08:15AM	Loading…
08:15AM	This Under-the-Radar Healthcare Stock Could Soar in 2026 (Motley Fool)
06:45AM	Takeda poaches top Lilly exec; Maze soars on early PKU drug data (BioPharma Dive)
04:44AM	1 Super Stock Down More Than 20% to Buy Hand Over Fist, According to Wall Street (Motley Fool)
03:00AM	Pfizer Is Growing More Reliant on Vaccines as Controversies Swirl (Barrons.com)
Sep-11-25 10:57PM	Analyst Report: Elanco Animal Health Incorporated (Morningstar Research)
04:22PM	Vanguard's VUG ETF: The Ultimate Growth ETF for Your Portfolio (MarketBeat)
01:29PM	Eli Lilly loses appeal of $183.7 million Medicaid fraud award (Reuters)
10:02AM	Where Does VKTX Stock Stand After the Obesity Pill Setback? (Zacks)
10:00AM	Lilly to participate in Bernstein's 2nd Annual Healthcare Forum (PR Newswire)
09:40AM	Novo Nordisk tells staff to return to office full-time amid CEO's revival effort (Reuters)
08:45AM	Loading…
08:45AM	Why Eli Lilly's Stock Could Be Gearing Up for a Big Rally (Motley Fool)
07:00AM	GE HealthCare inks Icometrix buyout to acquire brain MRI software (MedTech Dive)
06:57AM	AI Stocks Are Driving This Market Rally. Why It's Not a Dot-Com Bubble Repeat. (Barrons.com)
06:30AM	Chinas Multibillion-Dollar US Pharma Pipeline Draws Scrutiny in Washington (The Daily Upside)
04:25AM	Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novartis, Pfizer and Bayer (Zacks)
04:20AM	2 Monster Stocks to Hold for the Next 5 Years (Motley Fool)
Sep-10-25 04:31PM	Wegovy And Zepbound Cost Effective But They Could Break Drug Budgets (Benzinga)
02:32PM	Rate of employers covering weight-loss drugs is flat, Cigna says (Reuters)
12:12PM	Trump's Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales. (Barrons.com)
12:06PM	Ascletis GLP-1RA shows promise with quarterly dosing schedule (Clinical Trials Arena)
11:08AM	5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds (Zacks)
10:28AM	Is NVO's Major Restructuring Plan an Indication to Sell the Stock? (Zacks)
10:10AM	Ozempic maker Novo Nordisk to cut 11% of workforce (Quartz)
09:48AM	Oracles $230 Billion Market Cap Surge to Lift It Above JPMorgan (Bloomberg)
09:30AM	Eli Lilly (LLY) Just Reclaimed the 50-Day Moving Average (Zacks)
09:09AM	Loading…
09:09AM	Wegovy and Ozempic maker to cut 9,000 jobs amid stiff competition from Eli Lilly (CNN Business)
07:42AM	Novo Nordisk slashes 11% of workforce as Eli Lilly pressure tightens (Pharmaceutical Technology)
07:00AM	Shorts Are Returning to AppLovin Even After $3.2 Billion Squeeze (Bloomberg)
05:23AM	Novo Nordisk to cut 9,000 jobs as Eli Lilly competition intensifies (Euronews)
05:18AM	Wegovy-maker Novo Nordisk to slash 9,000 jobs as competition grows (Reuters Videos)
04:27AM	Ozempic maker to cut 9,000 jobs (The Telegraph)
01:07AM	Novo Nordisk slashes 9,000 jobs to slim down in fierce weight-loss drug battle (Reuters)
Sep-09-25 11:56PM	UBS Sees $15 Billion Sales Potential for Eli Lilly's (LLY) Obesity Treatment Orforglipron (Insider Monkey)
12:59PM	Lilly to give biotech startups access to AI tools (BioPharma Dive)
11:37AM	Cracker Barrel, Eli Lilly, Wolfspeed: Trending Tickers (Yahoo Finance Video)
11:34AM	LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal (Zacks)
11:21AM	Will LLY's Oncology Portfolio Provide Key Diversification Benefits? (Zacks)
10:02AM	Weight-loss drugs becoming better value for money, says watchdog (Quartz)
08:50AM	Will Merck's Cost Cuts and New Drug Approvals Ease Headwinds? (Zacks)
08:05AM	Pricing group says weight-loss drugs becoming more cost-effective (Reuters)
08:00AM	Lilly launches new "Brain Health Matters" campaign in partnership with Julianne Moore, empowering the public to prioritize brain health (PR Newswire)
07:11AM	Lilly to seek Jaypirca label expansion for first-line CLL/SLL usage (Pharmaceutical Technology)
07:09AM	Lilly launches AI-powered platform to accelerate drug discovery (Reuters)
07:00AM	Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment (PR Newswire)
12:41AM	2 Growth Stocks with Explosive Upside and 1 We Brush Off (StockStory)
Sep-08-25 09:00PM	1 Reason Every Investor Should Know About Novo Nordisk (NVO) (Motley Fool)
07:33PM	Eli Lilly (LLY) Laps the Stock Market: Here's Why (Zacks)
04:29PM	Here's How Much You'd Have If You Invested $1000 in Eli Lilly a Decade Ago (Zacks)
01:59PM	WHO adds GLP-1RAs to essential medicines list (Pharmaceutical Technology)
11:27AM	NKTR Shares Surge 38.2% in a Week: Here's What You Should Know (Zacks)
09:42AM	Investing in Oncology: 3 Cancer Stocks With Promising Pipelines (Zacks)
06:45AM	Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, significantly improved progression-free survival in patients with treatment-naive CLL/SLL (PR Newswire)
Sep-07-25 11:32PM	Unpacking Q2 Earnings: Eli Lilly (NYSE:LLY) In The Context Of Other Branded Pharmaceuticals Stocks (StockStory)
Sep-06-25 06:42AM	3 Stocks to Buy and Hold Forever (Motley Fool)
01:12AM	Eli Lilly's Verzenio Significantly Improves Overall Survival in Early Breast Cancer Patients (Insider Monkey)
Sep-05-25 02:23PM	WHO adds weight loss drugs to essential medicines list (Quartz)
11:05AM	Jefferies Sees Huge Potential in Eli Lilly's (LLY) New Weight-Loss Pill (Insider Monkey)
09:00AM	Is Eli Lilly Stock a Buy After Gaining 5% in 1 Day? (Motley Fool)
07:46AM	Weight loss has become the hottest new Chinese consumer craze (MarketWatch)
07:30AM	FDA grants breakthrough therapy status to Eli Lilly's olomorasib (Pharmaceutical Business Review)
06:43AM	EMA warns of rise in illegal weight loss drugs marketed online (Pharmaceutical Technology)
06:00AM	Why weight-loss 'wonder drugs' aren't 'wonder stocks' yet (Yahoo Finance)
04:29AM	2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street Analysts (Motley Fool)
04:10AM	Down 34%, Should You Buy the Dip on Viking Therapeutics? (Motley Fool)
Sep-04-25 04:14PM	Sanofi Tumbles As New Eczema Drug Lags Dupixent's 'Compelling Bar' (Investor's Business Daily)
03:00PM	Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity? (Zacks)
02:20PM	Healthcare Stocks Are Just Starting Their Resurgence. Hold On to Them. (Barrons.com)
06:45AM	Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancers (PR Newswire)
04:25AM	Where Will Eli Lilly Be in 3 Years? (Motley Fool)
03:45AM	Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris (Zacks)
Sep-03-25 05:52PM	Eli Lilly Wins Fresh Bullish Call From BMO (GuruFocus.com)
02:09PM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
01:48PM	The Problem With Weight Loss Stocks (Motley Fool)
01:19PM	Hims & Hers gains after court rejects Eli Lillys case against Willow (Investing.com)
12:12PM	Jim Cramer Urges Patience With Eli Lilly and Company (LLY)'s Stock (Insider Monkey)
11:30AM	Insider Watch: 3 CEOs Buying the Dip (Zacks)
06:30AM	Lung Disease Breakthrough Boosts United Therapeutics and its Rivals (The Daily Upside)
05:07AM	Is Novo Nordisk Stock a Buy Now? (Motley Fool)
03:55AM	Zacks Investment Ideas feature highlights: Eli Lilly, Eaton and Interactive Brokers (Zacks)
Sep-02-25 04:49PM	Stocks to Watch Recap: Alphabet, Nvidia, Comerica, Constellation Brands (The Wall Street Journal)
04:48PM	More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off. (Barrons.com)
04:25PM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
12:59PM	Stocks to Watch Tuesday: Nvidia, Eli Lilly, PepsiCo, Constellation Brands (The Wall Street Journal)
11:30AM	These 3 Companies are Seeing Supercharged Sales Growth (Zacks)
11:13AM	BMO Capital Affirms Eli Lilly (LLY)'s 'Outperform' Rating on Weight Loss Drug Prospects (Insider Monkey)
10:30AM	Viking Therapeutics Loses 20% in a Month: How to Play the Stock (Zacks)
10:01AM	Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales (Zacks)
09:48AM	GSK Adds Around $5B in a Month: Here's How to Play the Stock (Zacks)
09:05AM	Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke And Death (Benzinga)
06:04AM	Chinese companies turn to generics as shipments behind US weight-loss craze fade (Reuters)
04:03AM	Eli Lilly and Company (LLY)'s Oral Obesity Drug Orforglipron Achieves Breakthrough Phase 3 Results (Insider Monkey)
03:26AM	Eli Lilly and Company (LLY) Halts UK Mounjaro Shipments Ahead of Planned Price Increase (Insider Monkey)
Sep-01-25 11:59AM	Pfizer's Golden Cross Signals Strength: How to Play the Stock (Zacks)
10:54AM	NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction? (Zacks)
10:31AM	Biogen Secures FDA Nod for Subcutaneous Maintenance Dosing of Leqembi (Zacks)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience